Exploring the resistance mechanism of imipenem in carbapenem hydrolysing class D beta-lactamases OXA-143 and its variant OXA-231 (D224A) expressing Acinetobacter baumannii: An in-silico approach

Acinetobacter baumannii (A. baumannii), is a Gram negative, coccobacilli and is associated with nosocomial infections. The bacterium has developed resistance to all known classes of antibiotics. Multi-drug resistant A. baumannii infections have been treated with the carbapenem group of antibiotics like imipenem and meropenem. Recent reports indicate that A. baumannii has acquired resistance to imipenem due to the secretion of carbapenem hydrolysing class D beta-lactamases (CHDLs). Such CHDLs found in carbapenem resistant A. baumannii belongs to OXA-143 and its variant OXA-231, which has Alanine (A) in place of Aspartic acid (D) at sequence position 224. The mutation of the OXA-231 CHDL alters the catalytic activity of the enzyme. Hence, the present study was carried out to find the probable mechanism of imipenem resistance in OXA-143 and OXA-231 (D224A) CHDLs expressing A. baumannii by employing molecular docking and dynamics. Methods Our study reveals that OXA-143 CHDL-imipenem complex has more binding affinity than OXA-231 (D224A) CHDL-imipenem complex. Our results indicate that there is a strong binding affinity of OXA-143 with imipenem when compared with OXA-243 and this mechanism might be the probable reason for imipenem resistance in OXA-143 expressing A. baumannii strains.

[1]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[2]  J. Garnacho-Montero,et al.  Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[4]  Jale Moradi,et al.  Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature , 2015, Osong public health and research perspectives.

[5]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[6]  P. Nordmann,et al.  OXA-143, a Novel Carbapenem-Hydrolyzing Class D β-Lactamase in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.

[7]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[8]  D. Eisenberg,et al.  VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.

[9]  N. Woodford,et al.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. , 2006, International journal of antimicrobial agents.

[10]  Anand Anbarasu,et al.  Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins. , 2014, Molecular bioSystems.

[11]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[12]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[13]  H. Berendsen,et al.  Interaction Models for Water in Relation to Protein Hydration , 1981 .

[14]  G. Bou,et al.  Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis , 2007, Proceedings of the National Academy of Sciences.

[15]  Piero Fariselli,et al.  I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure , 2005, Nucleic Acids Res..

[16]  Sudha Ramaiah,et al.  Molecular Docking and Molecular Dynamics Studies to Identify Potential OXA-10 Extended Spectrum β-Lactamase Non-hydrolysing Inhibitors for Pseudomonas aeruginosa , 2016, Cell Biochemistry and Biophysics.

[17]  T. Jang,et al.  Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. , 2009, The Journal of hospital infection.

[18]  G. V. Paolini,et al.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..

[19]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[20]  C. H. Camargo,et al.  Population Structure Analysis of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Brazil Reveals Predominance of Clonal Complexes 1, 15, and 79 , 2016, Antimicrobial Agents and Chemotherapy.

[21]  Lisa L Maragakis,et al.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  P. Higgins,et al.  OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.

[23]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[24]  A. N. Jain,et al.  Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. , 1996, Chemistry & biology.

[25]  R. López-Rojas,et al.  Emerging therapies for multidrug resistant Acinetobacter baumannii. , 2013, Trends in microbiology.

[26]  Tae Hyong Kim,et al.  Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii: a Case-Control Study , 2004, Antimicrobial Agents and Chemotherapy.

[27]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[28]  A. Sali,et al.  Modeller: generation and refinement of homology-based protein structure models. , 2003, Methods in enzymology.

[29]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[30]  F. Rossi,et al.  High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. , 2012, International journal of antimicrobial agents.

[31]  S. Bryant,et al.  PubChem as a public resource for drug discovery. , 2010, Drug discovery today.

[32]  Fabian Sievers,et al.  Clustal Omega, accurate alignment of very large numbers of sequences. , 2014, Methods in molecular biology.

[33]  Mark Johnson,et al.  NCBI BLAST: a better web interface , 2008, Nucleic Acids Res..

[34]  I. Kuntz,et al.  Automated docking with grid‐based energy evaluation , 1992 .

[35]  A. Gales,et al.  Detection of OXA-231, a new variant of blaOXA-143, in Acinetobacter baumannii from Brazil: a case report. , 2012, The Journal of antimicrobial chemotherapy.

[36]  A. Barakat,et al.  Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[37]  P. Higgins,et al.  Characterization of blaOXA-143 Variants in Acinetobacter baumannii and Acinetobacter pittii , 2014, Antimicrobial Agents and Chemotherapy.

[38]  Amy C. Anderson,et al.  Scoring Ensembles of Docked Protein: Ligand Interactions for Virtual Lead Optimization , 2009, J. Chem. Inf. Model..

[39]  Sudha Ramaiah,et al.  Molecular dynamics and molecular docking studies on E166A point mutant, R274N/R276N double mutant, and E166A/R274N/R276N triple mutant forms of class A β-lactamases , 2014, Journal of biomolecular structure & dynamics.

[40]  D. Yong,et al.  Risk factors and outcomes of bloodstream infections with metallo-β-lactamase-producing Acinetobacter , 2008, Scandinavian journal of infectious diseases.

[41]  Y. Martin,et al.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.

[42]  Roger Fletcher,et al.  A Rapidly Convergent Descent Method for Minimization , 1963, Comput. J..

[43]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[44]  P. Nordmann,et al.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[45]  Ajay N. Jain.  Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.

[46]  Douglas E. V. Pires,et al.  DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach , 2014, Nucleic Acids Res..

[47]  D. Ehmann,et al.  Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48. , 2015, ACS chemical biology.

[48]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[49]  E Bergogne-Bérézin,et al.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features , 1996, Clinical microbiology reviews.

[50]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[51]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .